Lorenzo Gianni

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

Medicine, Oncology, Pharmacology +17

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

Marco Colleoni, Zhuoxin Sun, Karen N. Price et al. · Journal of Clinical Oncology · 2016 · 623 citations

Medicine, Biostatistics, Oncology +17

Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.

Ilaria Panzini, Lorenzo Gianni, Pier Paolo Fattori et al. · PubMed · 2002 · 198 citations

Medicine, Oncology, Surgery +17

Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients

Giuseppe Visani, Carlo Finelli, U. Castelli et al. · British Journal of Haematology · 1990 · 193 citations

Medicine, Hematology, Oncology +12

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00

Giancarlo Pruneri, Kathryn P. Gray, Andrea Vingiani et al. · Breast Cancer Research and Treatment · 2016 · 122 citations · Full text

Medicine, Immunology, Oncology +17